Showing results (2221-2230 of 3,022) with videos related to

Sort By:
Pageof 303
World Journal of Transplantation|July 1, 2024
Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantationSophia Hatzianastasiou, Paraskevas Vlachos, Georgios Stravopodis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2023
Dual effector population modification gene-drive strains of the African malaria mosquitoes, Anopheles gambiae and Anopheles coluzziiRebeca Carballar-Lejarazú, Yuemei Dong, Thai Binh Pham, et al.
Cancers|June 2, 2021
Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma PatientsKristine A Frerichs, Christie P M Verkleij, Meletios A Dimopoulos, et al.
British Journal of Haematology|August 15, 2023
Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab-based therapyFoteini Theodorakakou, Despina Fotiou, Vasiliki Spiliopoulou, et al.
Leukemia|April 25, 2020
Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myelomaHartmut Goldschmidt, Meletios A Dimopoulos, S Vincent Rajkumar, et al.
Science (New York, N.Y.)|August 5, 2006
Regulation of sexual development of Plasmodium by translational repressionGunnar R Mair, Joanna A M Braks, Lindsey S Garver, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal functionM A Dimopoulos, E Kastritis, E Michalis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 13, 2012
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patientsM Ruhnke, J A Paiva, W Meersseman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trialV Georgoulias, C Kouroussis, N Androulakis, et al.
Anticancer Research|January 25, 2008
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II studyP Kosmidis, G Fountzilas, S Baka, et al.
Pageof 303